Tuesday
May072013
NCT01850238
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer's Disease
Sponsors: Axon Neuroscience
Phase: I
KLH in Clinical Trials
Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.
Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.
(in order by date)
Friday
Nov232012
NCT01741038
Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer
Condition: Breast Cancer
Sponsors: Immunovative Therapies
Phase: II/III
Tuesday
Jul172012
NCT01644968
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I
Friday
Mar092012
NCT01552681
Baminercept in Sjögren's Syndrome
Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II
Date: March 9, 2012
Categories Immune Disease - Autoimmune
Thursday
Jan192012
NCT01516307
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Conditions: Metastatic Breast Cancer
Sponsors: Optimer Biotechnology, Inc.
Phase II
Date: January 19, 2012
Categories Cancer - Breast
Monday
Jan092012
NCT01509391
Keyhole Limpet Hemocyanin in Chronic Hepatitis C (IM1)
Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a
Date: January 9, 2012
Categories Hepatitis C, Infectious Disease, Liver Disease
Monday
Jan092012
2011-004394-90
Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1
Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a
Date: January 9, 2012
Categories Hepatitis C, Infectious Disease, Liver Disease
Wednesday
Dec212011
NCT01498328
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)
Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase II
Date: December 21, 2011
Categories Cancer - Brain & CNS
Thursday
Dec012011
NCT01489956
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase 0
Date: December 1, 2011
Categories Healthy, Immune Disease - Autoimmune
Monday
Nov212011
NCT01480479
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)
Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase III
Date: November 21, 2011
Categories Cancer - Brain & CNS